1 January 2025 false Taxfiler 2024.6 13835249business:PrivateLimitedCompanyLtd2025-01-012026-04-30 138352492024-12-31 138352492025-01-012026-04-30 13835249business:AuditExemptWithAccountantsReport2025-01-012026-04-30 13835249business:FilletedAccounts2025-01-012026-04-30 138352492026-04-30 13835249business:Director12025-01-012026-04-30 13835249business:Director22025-01-012026-04-30 13835249business:RegisteredOffice2025-01-012026-04-30 138352492024-12-31 13835249core:WithinOneYear2026-04-30 13835249core:WithinOneYear2024-12-31 13835249core:AfterOneYear2026-04-30 13835249core:AfterOneYear2024-12-31 13835249core:ShareCapitalcore:PreviouslyStatedAmount2026-04-30 13835249core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 13835249core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2026-04-30 13835249core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 13835249core:PreviouslyStatedAmount2026-04-30 13835249core:PreviouslyStatedAmount2024-12-31 13835249business:SmallEntities2025-01-012026-04-30 13835249countries:EnglandWales2025-01-012026-04-30 13835249core:FurnitureFittings2025-01-012026-04-30 13835249core:FurnitureFittings2024-12-31 13835249core:FurnitureFittings2026-04-30 13835249business:OrdinaryShareClass12025-01-012026-04-30 13835249business:OrdinaryShareClass12024-01-012024-12-31 138352492024-01-012024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 13835249 (England and Wales)
Jan Therapies Limited Unaudited accounts for the period from 1 January 2025 to 30 April 2026
Jan Therapies Limited Unaudited accounts Contents
Page
- 2 -
Jan Therapies Limited Company Information for the period from 1 January 2025 to 30 April 2026
Directors
Jandaeng Hawkins Anthony Paul Morris
Company Number
13835249 (England and Wales)
Registered Office
Venta House 9a Port Road Maesglas Retail Estate Newport NP20 2NS United Kingdom
Accountants
Evans Entwistle Venta House Maes-glas Newport NP20 2NS
- 3 -
Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Jan Therapies Limited for the period from 1 January 2025 to 30 April 2026
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Jan Therapies Limited for the period from 1 January 2025 to 30 April 2026 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.
As a CIMA Registered Member in Practice and Practising Certificate holder, I am subject to its ethical and other professional requirements which are detailed at https://www.cimaglobal.com/Members/Your-Membership-Information/Members-handbook/Licensing-and-monitoring/Members-in-practice/
Our work has been undertaken in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com.
Evans Entwistle Member in Practice Venta House Maes-glas Newport NP20 2NS 14 July 2026
- 4 -
Jan Therapies Limited Statement of financial position as at 30 April 2026
2026 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
- 
6,750 
Current assets
Cash at bank and in hand
803 
3,189 
Creditors: amounts falling due within one year
(1,200)
(876)
Net current (liabilities)/assets
(397)
2,313 
Total assets less current liabilities
(397)
9,063 
Creditors: amounts falling due after more than one year
(16,938)
(20,512)
Provisions for liabilities
Deferred tax
- 
(1,283)
Net liabilities
(17,335)
(12,732)
Capital and reserves
Called up share capital
2 
2 
Profit and loss account
(17,337)
(12,734)
Shareholders' funds
(17,335)
(12,732)
For the period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 14 July 2026 and were signed on its behalf by
Anthony Paul Morris Director Company Registration No. 13835249
- 5 -
Jan Therapies Limited Notes to the Accounts for the period from 1 January 2025 to 30 April 2026
1
Statutory information
Jan Therapies Limited is a private company, limited by shares, registered in England and Wales, registration number 13835249. The registered office is Venta House 9a Port Road, Maesglas Retail Estate, Newport, NP20 2NS, United Kingdom. The company is in the process of being wound up.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
5 years straight-line
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
- 6 -
Jan Therapies Limited Notes to the Accounts for the period from 1 January 2025 to 30 April 2026
4
Tangible fixed assets
Fixtures & fittings 
£ 
Cost or valuation
At cost 
At 1 January 2025
15,000 
Disposals
(15,000)
At 30 April 2026
- 
Depreciation
At 1 January 2025
8,250 
On disposals
(8,250)
At 30 April 2026
- 
Net book value
At 30 April 2026
- 
At 31 December 2024
6,750 
5
Creditors: amounts falling due within one year
2026 
2024 
£ 
£ 
Accruals
1,200 
876 
6
Creditors: amounts falling due after more than one year
2026 
2024 
£ 
£ 
Loans from directors
16,938 
20,512 
7
Share capital
2026 
2024 
£ 
£ 
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2 
2 
8
Average number of employees
During the period the average number of employees was 1 (2024: 1).
- 7 -